All Penny Stocks.com News: ProtoKinetix's AAGP(TM) Improves Results in Stem Cells Transplanted in Retina Significantly

Mississauga, ON -- (SBWIRE) -- 05/02/2016 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "ProtoKinetix's AAGP(TM) Improves Results in Stem Cells Transplanted in Retina Significantly."

Companies mentioned in this article include iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) and ProtoKinetix Inc. (OTCQB:PKTX).

Article Excerpt:

After a short relief rally that lasted nearly a month, the biotech sector is seeing a correction. Indeed, over the past five trading sessions, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) has dropped more than 7%.

The IBB has also dropped below a key support level during this correction. The drop below a key technical level suggests that the market sentiment has once again turned bearish on the biotech sector. The sector had had a disastrous start to 2016 as it saw a huge sell-off in January and February. However, at the end of March, the IBB began recovering and the relief rally lasted nearly a month.

The latest pullback in the biotech sector has been caused by some disappointing earnings from major biotech companies over the past week. But all is not gloomy with the sector. This morning, ProtoKinetix Inc. (OTCQB:PKTX) announced some positive developments, even though shares were challenged with slight declines today along with the broader sector.

The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/635/protokinetixs-aagptm-improves-results-in-stem-cells-transplanted-in-retina-significantly.htm

About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.

AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.

Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.

Contact:

AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com

Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.

For more information on this press release visit: http://www.sbwire.com/press-releases/all-penny-stockscom-news-protokinetixs-aagptm-improves-results-in-stem-cells-transplanted-in-retina-significantly-686175.htm

Media Relations Contact

Peter Szafranski
Telephone: 905-361-5680
Email: Click to Email Peter Szafranski
Web: http://www.allpennystocks.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X